uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Acute Myeloid Leukemia in Adolescents and Young Adults Treated in Pediatric and Adult Departments in the Nordic Countries
Sahlgrens Univ Hosp, Dept Hematol & Coagulat, Dept Internal Med, Gothenburg, Sweden..
Aarhus Univ Hosp, Dept Pediat, DK-8200 Aarhus, Denmark..
Queen Silvia Childrens Hosp, Dept Pediat, Gothenburg, Sweden..
Aarhus Univ Hosp, Dept Hematol, DK-8200 Aarhus, Denmark..
Show others and affiliations
2016 (English)In: Pediatric Blood & Cancer, ISSN 1545-5009, E-ISSN 1545-5017, Vol. 63, no 1, 83-92 p.Article in journal (Refereed) Published
Resource type
Text
Abstract [en]

BackgroundStudies on adolescents and young adults with acute lymphoblastic leukemia suggest better results when using pediatric protocols for adult patients, while corresponding data for acute myeloid leukemia (AML) are limited. ProcedureWe investigated disease characteristics and outcome for de novo AML patients 10-30 years old treated in pediatric or adult departments. We included 166 patients 10-18 years of age with AML treated according to the pediatric NOPHO-protocols (1993-2009) compared with 253 patients aged 15-30 years treated in hematology departments (1996-2009) in the Nordic countries. ResultsThe incidence of AML was 4.9/million/year for the age group 10-14 years, 6.5 for 15-18 years, and 6.9 for 19-30 years. Acute promyelocytic leukemia (APL) was more frequent in adults and in females of all ages. Pediatric patients with APL had similar overall survival as pediatric patients without APL. Overall survival at 5 years was 60% (52-68%) for pediatric patients compared to 65% (58-70%) for adult patients. Cytogenetics and presenting white blood cell count were the only independent prognostic factors for overall survival. Age was not an independent prognostic factor. ConclusionsNo difference was found in outcome for AML patients age 10-30 years treated according to pediatric as compared to adult protocols. Pediatr Blood Cancer 2015; 9999:1-10

Place, publisher, year, edition, pages
2016. Vol. 63, no 1, 83-92 p.
Keyword [en]
acute myeloid leukemia, adolescents, age, outcome, young adults
National Category
Cancer and Oncology Pediatrics
Identifiers
URN: urn:nbn:se:uu:diva-274431DOI: 10.1002/pbc.25713ISI: 000367097800013OAI: oai:DiVA.org:uu-274431DiVA: diva2:896524
Funder
Swedish Childhood Cancer Foundation
Available from: 2016-01-21 Created: 2016-01-21 Last updated: 2017-11-30Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full text

Authority records BETA

Palle, Josefine

Search in DiVA

By author/editor
Palle, Josefine
By organisation
Pediatrics
In the same journal
Pediatric Blood & Cancer
Cancer and OncologyPediatrics

Search outside of DiVA

GoogleGoogle Scholar

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 448 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf